Editas Medicine (EDIT) Other Non Operating Income (2015 - 2025)
Editas Medicine (EDIT) reported Other Non Operating Income of -$1000.0 for Q3 2025, up 80.0% year-over-year from -$555.56 in Q3 2024, and up 99.94% quarter-over-quarter from -$1.8 million in Q2 2025.
Editas Medicine (EDIT) Other Non Operating Income (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Other Non Operating Income data on file, last reported at -$1000.0 in Q3 2025.
- Other Non Operating Income for Q3 2025 came in at -$1000.0, up 80.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.2 million (down 15521.43% YoY), and the FY2024 annual result was -$3000.0, up 99.81% from the prior year.
- Other Non Operating Income advanced to -$1000.0 in Q3 2025 per EDIT's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $235000.0 in Q2 2022 and troughed at -$1.8 million in Q2 2025.
- A 5-year average of -$208666.7 and a median of -$2000.0 in 2021 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income surged 23600.0% in 2022, then slumped 175700.0% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$1000.0 in 2021, then sank by 300.0% to -$4000.0 in 2022, then slumped by 250.0% to -$14000.0 in 2023, then surged by 78.57% to -$3000.0 in 2024, then surged by 66.67% to -$1000.0 in 2025.
- Business Quant data shows EDIT's Other Non Operating Income at -$1000.0 in Q3 2025, -$1.8 million in Q2 2025, and -$425000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -425,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Jun 30, 2023 | -7,000.00 |
| Mar 31, 2023 | -1.58 Mn |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 235,000.00 |
| Mar 31, 2022 | -234,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 3.15 Mn |
| Sep 30, 2020 | -1.40 Mn |